AGBL3 and rheumatoid arthritis: In aggregate, these findings support that a combination of positivity of anti-CCP3 and these two RF isotypes, including persistent ‘dual’ positivity for these RFs over time, is strongly associated with the future onset of clinical IA/RA, as well as imminent RA, with additional influence from the SE.